Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort

Overview of attention for article published in Advances in Rheumatology, March 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 news story.

Treatment with secukinumab was proven to be a safe and effective option for patients with ankylosing spondylitis (AS) and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.